Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of the Novel HISCL Chemiluminescence Enzyme Immunoassay for Laboratory Screening of Hepatitis C Virus.

Literature DB >> 27170643

Evaluation of the Novel HISCL Chemiluminescence Enzyme Immunoassay for Laboratory Screening of Hepatitis C Virus.

Shu Feng¹, Bin Wei¹, Qianqian Liu¹, Tingting Wang¹, Dongdong Li¹, Chenli Rao¹, Chuanmin Tao², Lanlan Wang².

Abstract

The hepatitis C virus (HCV) antibody assay remains the first-line screening test to identify HCV infection. The newly arrived HISCL Anti-HCV assay had a satisfactory seroconversion sensitivity. Its sensitivity and specificity were 98.97 and 100% for clinical samples. In general, the HISCL Anti-HCV assay may be a novel choice for clinical HCV screening.

Entities: Disease Species

Mesh：

Substances：
Hepatitis C Antibodies

Year: 2016 PMID： 27170643 PMCID： PMC4933778 DOI： 10.1128/CVI.00078-16

Source DB: PubMed Journal: Clin Vaccine Immunol ISSN： 1556-679X

10 in total

1. Evaluation of the Elecsys(®) Anti-HCV II assay for routine hepatitis C virus screening of different Asian Pacific populations and detection of early infection.

Authors: Soo Jin Yoo; Lan Lan Wang; Hsiao-Chen Ning; Chuan Min Tao; Nattiya Hirankarn; Sunida Kuakarn; Ruifeng Yang; Tae Hee Han; Raymond C Chan; Baizurah Mohd Hussain; Hazilawati Hussin; Dewi Muliaty; Lisong Shen; Hongjing Liu; Lai Wei
Journal: J Clin Virol Date: 2014-12-30 Impact factor: 3.168

2. EASL recommendations on treatment of hepatitis C 2014.

Authors:
Journal: J Hepatol Date: 2014-05-10 Impact factor: 25.083

3. Performance evaluation and comparison of the newly developed Elecsys anti-HCV II assay with other widely used assays.

Authors: Ruifeng Yang; Wenli Guan; Qian Wang; Yan Liu; Lai Wei
Journal: Clin Chim Acta Date: 2013-09-18 Impact factor: 3.786

4. Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.

Authors: Shiji Wu; Yanling Liu; Liming Cheng; Botao Yin; Jing Peng; Ziyong Sun
Journal: J Med Virol Date: 2011-11 Impact factor: 2.327

5. Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity.

Authors: F Alborino; A Burighel; F-W Tiller; J van Helden; C Gabriel; A Raineri; R Catapano; H Stekel
Journal: Med Microbiol Immunol Date: 2010-09-24 Impact factor: 3.402

6. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.

Authors: Gérard Denoyel; Josef van Helden; Richard Bauer; Barbara Preisel-Simmons
Journal: Clin Lab Date: 2004 Impact factor: 1.138

7. Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection.

Authors: Hui-Ying Rao; Fu-Rong Ren; Wen-Li Guan; Michel Houde; Shao-Cai Du; Chang-Li Liu; Xiao-Yan Gong; Lai Wei
Journal: J Virol Methods Date: 2009-08-22 Impact factor: 2.014

8. Multicenter evaluation of the Elecsys® anti-HCV II assay for the diagnosis of hepatitis C virus infection.

Authors: Juan I Esteban; Josef van Helden; Flora Alborino; Philippe Bürgisser; Cristina Cellerai; Giuseppe Pantaleo; Adolfo Eiras; Maria I Rodriguez; Valeria Ghisetti; Michael Gleich; Roland Imdahl; Claudia Kaiser; Petra Möller; Olaf Wetlitzky; Manuel Segovia; Harald Schennach; Annelies Mühlbacher
Journal: J Med Virol Date: 2013-08 Impact factor: 2.327

9. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection.

Authors: Sinyoung Kim; Jeong-Ho Kim; Seoyoung Yoon; Youn-Hee Park; Hyon-Suk Kim
Journal: J Clin Microbiol Date: 2008-10-22 Impact factor: 5.948

10. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.

Authors: Adalbert Krawczyk; Christian Hintze; Jessica Ackermann; Birgit Goitowski; Martin Trippler; Nico Grüner; Maria Neumann-Fraune; Jens Verheyen; Melanie Fiedler
Journal: J Clin Virol Date: 2013-11-07 Impact factor: 3.168